title: Time for new schizophrenia Rx.
authors.affiliation: Steven E. Hyman is director of the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and the Massachusetts Institute of Technology in Cambridge, MA, and a professor in the Department of Stem Cell and Regenerative Biology at Harvard University, Cambridge, MA.
authors.forename: Steven E
authors.initials: SE
authors.lastname: Hyman
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D055808:Drug Discovery; D004345:Drug Industry / Q000639:trends; D011307:Drug Prescriptions; D006801:Humans; D007391:International Cooperation; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009316:National Institutes of Health (U.S.); D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics; D014481:United States
chemical_list: D014150:Antipsychotic Agents